Assessment of risk factors for transmission of bloodborne infections (hepatitis b, c and hiv) by intravenous catheter manipulation

View or download the full article: 
PDF icon health-risk-analysis-2025-4-11.pdf
UDC: 
616-092
DOI: 
10.21668/health.risk/2025.4.11.eng
Authors: 

А.V. Satsuk1,2, О.V. Pimenova1, Е.V. Klochkova1, G.А. Novichkova1, А.А. Ploskireva2, V.G. Akimkin2, G.G. Solopova1

Organization: 

1Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 1 Samory Mishela Str., Moscow, 117997, Russian Federation
2Central Research Institute of Epidemiology, 3 Novogireevskaya Str., build. 3, Moscow, 111123, Russian Federation

Abstract: 

Injections and infusions are a common cause of transmission of nosocomial bloodborne infections (hepatitis B, C and HIV). Venous catheters as the main venous access in oncohematological patients are the reason for high incidence of bloodborne infections in this group of patients.

The aim of the study was to determine the causes of transmission of bloodborne infections (hepatitis B, C and HIV) during manipulations with the central venous catheter (CVC).
A survey was conducted among 200 oncohematological nurses from «Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology» (Center) and regional oncohematological clinics. The purpose of the survey was to identify what errors and misconceptions healthcare workers have as regards manipulation with venous catheters.

In 27 % of cases, the nurses believed that it was impossible to infect patients with hepatitis B, C and HIV when working with CVC. In 65 % of cases, the respondents replied that in the absence of visible blood, there is no risk of transmission of bloodborne infections when working with CVC. The reuse of syringes, catheter plugs/caps, infusion lines and vials of drugs between patients was considered safe by 3, 4, 11 and 46 % of the nurses accordingly. Fifteen percent of the nurses considered it safe to take the drug from a multi-dose vial with a reused syringe. Use of a single work surface when working with CVC in several patients was considered safe by 36 % of the respondents; repeated use of gloves, by 13 %. Even repeated use of syringes for injections, provided that the needle was changed, was considered safe by 3 % of nurses.

This study showed a low level of knowledge and vigilance among the participating healthcare workers regarding transmission of bloodborne infections when working with intravenous catheters. The nurses' erroneous judgments regarding potential blood contamination were as follows: confidence in blood being absent in the catheter port (cannula); absence of blood reflux into areas of the infusion system remote from the patient (infusion line, vial) and safety of their repeated use in different patient;, absence of blood contamination on work surfaces and gloves.

Keywords: 
risk of transmission of bloodborne infections, hepatitis B, hepatitis C, HIV, intravenous catheter, vigilance of nurses, repeated use of disposable materials, multi-dose vials, unsafe injections, risk-associated manipulations
Satsuk А.V., Pimenova О.V., Klochkova Е.V., Novichkova G.А., Ploskireva А.А., Akimkin V.G., Solopova G.G. Assessment of risk factors for transmission of bloodborne infections (hepatitis B, C and HIV) by intravenous catheter manipulation. Health Risk Analysis, 2025, no. 4, pp. 114–122. DOI: 10.21668/health.risk/2025.4.11.eng
References: 
  1. Prati D. Transmission of hepatitis C virus by blood transfusion and other medical proce-dures: a global review. J. Hepatol., 2006, vol. 45, no. 4, pp. 607–616. DOI: 10.1016/j.jhep.2006.07.003
  2. Global status report on blood safety and availability 2016. WHO, 2017. Available at: https://apps.who.int/iris/bitstream/handle/10665/254987/9789241565431-en... (April 12, 2025).
  3. Lanini S., Puro V., Lauria F.N., Fusco F.M., Nisii C., Ippolito G. Patient to patient transmis-sion of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med., 2009, vol. 7, pp. 15. DOI: 10.1186/1741-7015-7-15
  4. Hauri A.M., Armstrong G.L., Hutin Y.J.F. The global burden of disease attributable to con-taminated injections given in health care settings. Int. J. STD AIDS, 2004, vol. 15, no. 1, pp. 7–16. DOI: 10.1258/095646204322637182
  5. Hayashi T., Hutin Y.J.-F., Bulterys M., Altaf A., Allegranzi B. Injection practices in 2011–2015: a review using data from the demographic and health surveys (DHS). BMC Health Serv. Res., 2019, vol. 19, no. 1, pp. 600. DOI: 10.1186/s12913-019-4366-9
  6. Sacuk A.V., Solopova G.G., Ploskireva A.A. A systematic review of outbreaks of blood-borne infections (hepatitis B and C, HIV) transmitted from patient to patient in healthcare settings. Zhurnal mikrobiologii, epidemiologii i immunobiologii, 2021, vol. 98, no. 3, pp. 319–330. DOI: 10.36233/0372-9311-112 (in Russian).
  7. Satsuk A.V., Solopova G.G., Begunova S.V., Rozantseva E.V., Ploskireva A.A., Akimkin V.G. The prevalence of bloodborne infections (hepatitis B and C, human immunodeficiency virus) among pediatric patients with oncological and hematological diseases and immunodeficiencies. Voprosy gematologii/onkologii i immunopatologii v pediatrii, 2021, vol. 20, no. 4, pp. 100–106. DOI: 10.24287/1726-1708-2021-20-4-100-106 (in Russian).
  8. Ladnaia N.N., Dementyeva L.A., Kurganova O.P., Ploskireva A.A., Pimenov N.N., Burdinskaya E.N., Yurgina O.M., Kozyrina N.V. [et al.]. Epidemiological investigation of infection cases in children with hepatitis C virus in the Department of Hematological Oncology of the healthcare facility. Epidemiologiya i infektsionnye bolezni. Aktual'nye voprosy, 2022, vol. 12, no. 4, pp. 52–60. DOI: 10.18565/epidem.2022.12.4.52-60 (in Russian).
  9. Yarosh L.V., Semenenko T.A., Filatov F.P., Garanzha T.A., Tupoleva T.A., Elgort D.A., Konopleva M.V., Suslov A.P. Parenteral hepatitis in patients of hematology research center. In-fektsionnye bolezni, 2015, vol. 13, no. 4, pp. 5–9 (in Russian).
  10. Semenenko T.A., Nikitina G.Yu., Ptushkin V.V., Yarosh L.V., Kozhevnikova G.M., Polonskiy V.O., Suslov A.P. Prevalence of Occult and Mutant HBV Infection in Hospitalized Haematological Patients. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya, 2016, vol. 18, no. 1, pp. 56–62 (in Russian).
  11. Healthcare-Associated Hepatitis B and C Outbreaks (≥ 2 cases) Reported to the CDC 2008–2019. CDC, 2020, 29 p. Available at: https://www.cdc.gov/hepatitis/outbreaks/healthcarehepoutbreaktable.htm (November 18, 2024).
  12. Styczynski J., Wysocki M., Koltan S., Kurylak A. Epidemiologic aspects and preventive strategy of hepatitis B and C viral infections in children with cancer. Pediatr. Infect. Dis. J., 2001, vol. 20, no. 11, pp. 1042–1049. DOI: 10.1097/00006454-200111000-00008
  13. Said Z.N., El-Sayed M.H., El-Bishbishi I.A., El-Fouhil D.F., Abdel-Rheem S.E., El-Abedin M.Z., Salama I.I. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies. Liver Int., 2009, vol. 29, no. 4, pp. 518–524. DOI: 10.1111/j.1478-3231.2009.01975.x
  14. Pessoni G.C., Marinho T.A., Carneiro M.M.S., Martins R.M., Soares C.C., Silva L.N., Matos M.A., Arantes A.M. [et al.]. Hepatitis B virus infection among oncohematologic disease pa-tients in Central Brazil: prevalence, risk factors and immunization. Hematol. Transfus. Cell Ther., 2019, vol. 41, no. 3, pp. 199–204. DOI: 10.1016/j.htct.2018.11.008
  15. Kose S., Olmezoglu A., Gozaydin A., Ece G. Seroprevalence of hepatitis B and C among oncology patients in Turkey. J. Health Popul. Nutr., 2011, vol. 29, no. 6, pp. 652–655. DOI: 10.3329/jhpn.v29i6.9903
  16. Ramsey S.D., Unger J.M., Baker L.H., Little R.F., Loomba R., Hwang J.P., Chugh R., Koner¬man M.A. [et al.]. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices. JAMA Oncol., 2019, vol. 5, no. 4, pp. 497–505. DOI: 10.1001/jamaoncol.2018.6437
  17. Dencs A., Hettmann A., Martyin T., Jekkel C., Bányai T., Takács M. Phylogenetic investigation of nosocomial transmission of hepatitis C virus in an oncology ward. J. Med. Virol., 2011, vol. 83, no. 3, pp. 428–436. DOI: 10.1002/jmv.21983
  18. Büchner A., Du Plessis N.M., Reynders D.T., Omar F.E., Mayaphi S.H., Haeri Mazanderani A.F., Avenant T. Nosocomial outbreak of hepatitis B virus infection in a pediatric hematology and oncology unit in South Africa: Epidemiological investigation and measures to prevent further transmission. Pediatr. Blood Cancer, 2015, vol. 62, no. 11, pp. 1914–1919. DOI: 10.1002/pbc.25605
  19. Kološová A., Gašparovič J. Viral hepatitis B and C outbreak related to parenteral treatment at an oncological department in Slovakia. J. Hosp. Infect., 2016, vol. 93, no. 2, pp. 211–214. DOI: 10.1016/j.jhin.2016.01.013
  20. Kebudi R., Ayan I., Yílmaz G., Akící F., Görgün O., Badur S. Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey. Med. Pediatr. Oncol., 2000, vol. 34, no. 2, pp. 102–105. DOI: 10.1002/(sici)1096-911x(200002)34:23.0.co;2-#
Received: 
09.04.2025
Approved: 
28.10.2025
Accepted for publication: 
26.12.2025

You are here

Home